Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal

Vanderbilt University partners with ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders

Vanderbilt receives $20 million from The William K. Warren Foundation to further treatments for brain disorders